14091
恰加斯病 在拉丁美洲大陆 的贫困人群 中流行,但在其他国家和大陆也越来越多地被发现。
Chagas disease is prevalent among poor populations of continental Latin America but is increasingly being detected in other countries and continents.
查看中文全文00404
查看英文全文00404
14092
该病通常被称为“沉默和被沉默的疾病”,因为大多数感染者 没有症状或症状极其轻微。
It is often termed as a “silent and silenced disease” as the infected majority have no symptoms or extremely mild symptom.
查看中文全文00404
查看英文全文00404
14093
恰加斯病患者 属于可能出现重症COVID-19 的危险人群,应优先获得疫苗接种 。
Chagas disease patients comprise risk groups that can present severe forms of COVID-19 and should be prioritized for vaccination .
查看中文全文00404
查看英文全文00404
14094
全世界约有600-700万人感染恰加斯病 ,每年有1万人死亡。
There are approximately 6-7 million people infected with Chagas disease worldwide, with 10,000 deaths, every year.
查看中文全文00404
查看英文全文00404
14095
全球 有600-700万人感染 恰加斯病
6–7 million infected , worldwide
查看中文全文00404
查看英文全文00404
14096
每年约有1万人因恰加斯病 死亡
Approximately 10,000 disease-related deaths , every year
查看中文全文00404
查看英文全文00404
14097
7500万人面临感染 该病的风险
75 million people risk acquiring the disease
查看中文全文00404
查看英文全文00404
14098
全球缺少 创新型抗生素 助长了耐药性 的出现和蔓延
Global shortage of innovative antibiotics fuels emergence and spread of drug-resistance
查看中文全文00405
查看英文全文00405
14099
2021年4月15日 | 部门新闻
15 April 2021 | Departmental news
查看中文全文00405
查看英文全文00405
14100
世界卫生组织 的一份新报告指出,虽然人们越来越意识到抗生素耐药性 的直接威胁,但世界仍未能开发出迫切需要的抗菌疗法 。
The world is still failing to develop desperately needed antibacterial treatments , despite growing awareness of the urgent threat of antibiotic resistance , according to report by the World Health Organization .
查看中文全文00405
查看英文全文00405